CLOVIS ONCOLOGY INC. news, videos and press releases
For more news please use our advanced search feature.
CLOVIS ONCOLOGY INC. - More news...
CLOVIS ONCOLOGY INC. - More news...
- Thinking about buying stock in Clovis Oncology, Bank of America, Rivian Automotive, Rent the Runway, or Vipshop Holdings?
- Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286
- Thinking about buying stock in Pineapple Energy, Nio, SoFi Technologies, Clovis Oncology, or Rivian Automotive?
- Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat
- Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress
- Thinking about buying stock in Myovant Sciences, Clovis Oncology, FingerMotion, LogicBio Therapeutics, or Amplify Energy?
- TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations
- Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
- Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer
- Thinking about buying stock in Regulus Therapeutics, Nio, AMC Entertainment, Carvana, or Clovis Oncology?
- Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups
- Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
- Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
- Thinking about buying stock in Aprea Therapeutics, Dermata Therapeutics, Seres Therapeutics, Avadel Pharmaceuticals, or Clovis Oncology?
- Thinking about buying stock in Axsome Therapeutics, Nio, VEON, United Airlines, or Clovis Oncology?
- Thinking about buying stock in Energy Focus, Ford Motor, Clovis Oncology, Li Auto, or Rigel Pharmaceuticals?
- Thinking about buying stock in Clovis Oncology, Revlon, Sundial Growers, Xpeng, or Bitnile?
- Clovis Oncology Highlights Phase 1 Data from Ongoing Clinical Studies of Targeted Radiotherapy Candidate FAP-2286 at SNMMI Annual Meeting
- Thinking about buying stock in Clovis Oncology, Houston American Energy, Soleno Therapeutics, SeaChange International, or Norwegian Cruise Line?
- Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status
- Thinking about buying stock in Vinco Ventures, Digital Brands, Endo, Clovis Oncology, or Under Armour?
- Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference
- Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
- Clovis Oncology Highlights Rubraca® (Rucaparib) and FAP-2286 Data to be Presented at 2022 ASCO Annual Meeting
- Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4
- Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022
- Thinking about buying stock in Citius Pharmaceuticals, BioXcel Therapeutics, Array Technologies, Gogo, or Clovis Oncology?
- Clovis Oncology’s Rubraca® (Rucaparib) Significantly Improves Progression-Free Survival in First-line Maintenance Treatment in Women with Ovarian Cancer Regardless of Their Biomarker Status in Phase 3 ATHENA-MONO Trial
- Clovis Oncology and Evergreen Theragnostics Initiate Development and Manufacturing Services Agreement for Actinium-225-Labeled FAP-2286
- Thinking about buying stock in Eos Energy Enterprises, Norwegian Cruise Line, Marathon Digital, Clovis Oncology, or Atreca?
